Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
PTC Therapeutics (PTCT)
NASDAQ:PTCT
PTC Therapeutics (PTCT) Ownership Overview
1.41% Insiders
26.64% Mutual Funds
32.85% Other Institutional Investors
17.46% ETFs
21.65% Public Companies and Individual Investors
The ownership structure of PTC Therapeutics (PTCT) stock is a mix of institutional, retail, and individual investors. Approximately 76.94% of the company’s stock is owned by Institutional Investors, 1.41% is owned by Insiders, and 21.65% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 10, 2025 | Matthew B. Klein Ceo,director | xxxxxxxxxxxxx | $204007 |
| Jan 10, 2025 | Christine Marie Utter Svp & Cao | xxxxxxxxxxxxx | $132493 |
| Jan 10, 2025 | Eric Pauwels Ceo | xxxxxxxxxxxxx | $167551 |
| Jan 10, 2025 | Mark Elliott Boulding Exec. Vp And Clo | xxxxxxxxxxxxx | $158871 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $947940 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,398,111 | Institution | 9.59% | 383,370,112 | |
| 6,555,167 | Institution | 8.50% | 339,688,754 | |
| 4,025,556 | Institution | 5.22% | 208,604,312 | |
| 3,651,576 | Institution | 4.73% | 189,224,668 | |
| 1,095,290 | Institution | 1.42% | 56,757,928 | |
| 1,041,059 | Institution | 1.35% | 53,947,677 | |
| 995,729 | Institution | 1.29% | 51,598,677 | |
| 916,721 | Institution | 1.19% | 47,504,482 | |
| 881,729 | Institution | 1.14% | 45,691,197 | |
| 838,806 | Institution | 1.09% | 43,466,927 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,555,167 | Institution | 8.50% | 339,688,754 | |
| 4,025,556 | Institution | 5.22% | 208,604,312 | |
| 916,721 | Institution | 1.19% | 47,504,482 | |
| 881,729 | Institution | 1.14% | 45,691,197 | |
| 838,806 | Institution | 1.09% | 43,466,927 | |
| 820,126 | Institution | 1.06% | 42,498,929 | |
| 769,271 | Institution | 1.00% | 39,863,623 | |
| 595,711 | Institution | 0.77% | 30,869,744 | |
| 560,516 | Institution | 0.73% | 29,045,939 | |
| 480,611 | Institution | 0.62% | 24,905,262 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,405,586 | Institution | 3.12% | 108,588,152 | |
| 2,042,929 | Institution | 2.65% | 105,864,581 | |
| 1,963,994 | Institution | 2.55% | 88,654,689 | |
| 1,176,470 | Institution | 1.53% | 53,105,856 | |
| 1,114,194 | Institution | 1.44% | 50,294,717 | |
| 838,393 | Institution | 1.09% | 41,642,980 | |
| 516,328 | Institution | 0.67% | 26,756,117 | |
| 465,427 | Institution | 0.60% | 24,118,427 | |
| 371,673 | Institution | 0.48% | 18,460,998 | |
| 361,142 | Institution | 0.47% | 16,301,950 |
FAQ
Who Owns PTC Therapeutics (PTCT)?
According to the latest TipRanks data, approximately 32.85% of the company's stock is held by institutional investors, 1.41% is held by insiders, and 21.65% is held by retail investors.
What percentage of PTC Therapeutics (PTCT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 32.85% of PTC Therapeutics (PTCT) stock is held by institutional investors.
What percentage of PTC Therapeutics (PTCT) stock is held by retail investors?
According to the latest TipRanks data, approximately 21.65% of PTC Therapeutics (PTCT) stock is held by retail investors.
Who owns the most shares of PTC Therapeutics (PTCT)?
Vanguard owns the most shares of PTC Therapeutics (PTCT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.